| Bioactivity | Infigratinib-Boc is a derivative of Infigratinib containing a Boc (t-Butyloxy carbonyl) group. Infigratinib is an ATP-competitive pan-FGFR inhibitor[1]. | ||||||||||||
| Name | Infigratinib-Boc | ||||||||||||
| CAS | 2504949-83-9 | ||||||||||||
| Formula | C29H35Cl2N7O5 | ||||||||||||
| Molar Mass | 632.54 | ||||||||||||
| Appearance | 固体 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Guangyan Du, et al. Discovery of a Potent Degrader for Fibroblast Growth Factor Receptor 1/2. Angew Chem Int Ed Engl. 2021 Jul 12;60(29):15905-15911. |
Infigratinib-Boc
CAS: 2504949-83-9 F: C29H35Cl2N7O5 W: 632.54
Infigratinib-Boc is a derivative of Infigratinib containing a Boc (t-Butyloxy carbonyl) group. Infigratinib is an ATP-co
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.